CD82 may stabilize or strengthen E-cad-dependent intercellular adhesion by regulating β-catenin-mediated signal transduction on NSCLC cells and prevent cancer cells from seceding from the primary tumor site [50]. The gene discussed is CD82; the disease is cancer.